Navigation Links
Allon Therapeutics' CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
Date:3/7/2011

VANCOUVER, British Columbia, March 7, 2011 /PRNewswire/ -- Allon Therapeutics Inc. (TSX: NPC), today announced that their March 3rd RetailInvestorConferences.com presentation is available for on-demand viewing.

LINK: www.retailinvestorconferences.com Click the red "register/ watch events now" button.

Allon Therapeutics' presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.

About Allon Therapeutics Inc.:

Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on bringing to market innovative central nervous system therapies. Allon's lead drug davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under an SPA with the FDA. This pivotal trial is based upon statistically significant human efficacy demonstrated in amnestic mild cognitive impairment, cognitive impairment associated with schizophrenia, and positive biomarker data. The Company is listed on the Toronto Stock Exchange under the trading symbol "NPC" and based in Vancouver.

For additional information please visit the company's website: www.allontherapeutics.com

About RetailInvestorConferences.com:

RetailInvestorConferences.com, created by BetterInvesting (NAIC), PR Newswire and MUNCmedia, is the first monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire
'/>"/>

SOURCE Allon Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dr. Joan Fallon, Curemark CEO, Addresses Keystone Symposia Meeting On Autism
2. Allon Therapeutics to Present Live, Online at RetailInvestorConferences.com on March 3rd
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 On Tuesday, July ... filed suit in the 116 th Judicial ... , against RegenLab USA, LLC ("Defendant") ... Business Relationships through false and misleading actions, ... Business Disparagement through libel, disparagement, defamation, misrepresentation, ...
(Date:7/23/2014)... -- The Centers for Medicare & Medicaid Services (CMS) ... Organization (QIN-QIO) contract to a partnership led by the ... 1, WVMI will launch Quality Insights Quality Innovation Network ... Pennsylvania , Delaware , ... will engage providers and the community in multiple, data-driven ...
(Date:7/23/2014)... July 23, 2014  RT Oncology Services Corporation today ... join its board of directors. Mr. Mundie is currently ... he works on strategic projects within the company and ... chief research and strategy officer. ... RainTree, said, "Craig is a visionary technology executive. His ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... --,Alfacell Corporation today announced that in vivo study ... of non-small cell lung cancer (NSCLC) were recently,published ... Based on the work of Intae Lee, Ph.D., ... Efficacy of the Cytotoxic,RNase, Ranpirnase, on A549 Human ...
... Problem of Antibiotic Resistance,Published in Nature Biotechnology, VANCOUVER, ... Inc.'s product candidate IDR-1 is the first,immune system ... to a paper published in the April 2007,issue ... the work of Inimex and its,co-founders Dr. Bob ...
Cached Medicine Technology:In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 2In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 3Inimex Product Candidate is First Immune Defense Regulator to Cure,Infections Without Causing Harmful Inflammation 2
(Date:7/23/2014)... 2014 The North American market was valued ... grow at a CAGR of 10.79%, to reach $1,801.1 million ... America. , The North American Bromine Market report defines and ... of revenue. , Browse through the TOC of the North ... in-depth analysis provided. This also provides a glimpse of the ...
(Date:7/23/2014)... MI (PRWEB) July 23, 2014 A ... that gets clients off to a great start and ... believe in, has launched a new Internet Addiction section ... people are surprised to learn that Internet addiction is ... or drug addiction, but that it’s trapping more and ...
(Date:7/23/2014)... Drilling fluid and Completion fluid Market Report defines and segments ... analysis and forecast of revenue. The drilling fluid and completion ... $1.3 billion in 2013 to $1.7 billion by 2018, at ... through the TOC of the Europe drilling fluid and completion ... analysis provided. This also provides a glimpse of the segmentation ...
(Date:7/23/2014)... RFcnn.com, a distinguished electrical equipment retailer, has ... . What’s more, the company has decided to provide big ... who place an order for the company’s brand new SMA ... , The high quality SMA JACK from RFcnn.com Provides ... superb quality electrical equipment to help make things much easier ...
(Date:7/23/2014)... 23, 2014) Statins, a class of drugs commonly ... risk of developing Barrett,s esophagus, according to a new ... the official journal of the American Gastroenterological Association. Obese ... statin use. , "Patients who received statins had a ... esophagus compared to non-users," said study author Hashem B. ...
Breaking Medicine News(10 mins):Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 4Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 6Health News:New Collection of SMA JACK Released by China Electrical Accessory Manufacturer RFcnn 2Health News:Statin use decreases the risk of Barrett's esophagus 2
... type of bark with right canine expression, researcher says , ... A new study suggests that 6-month-old babies know the answer. ... figure out that an aggressive bark goes with an angry-looking ... their feelings in a different way. , The babies managed ...
... OLYMPIA, Wash., July 24 Washington Drug Card is ... healthcare facilities the ability to private label the free drug ... own custom cards so that they can receive credit for ... drug card program. , , ...
... is surgery or percutaneous aspiration, injection and reaspiration (PAIR) ... causing permanent damage to the endocyst - the thin, ... fluid and generates new larval elements able to expand ... can result in biliary or bronchial fistulae, prompted by ...
... 24 /PRNewswire-Asia/ -- Neusoft Medical Systems Co.,Ltd. (Neusoft Medical), ... that its newly developed Computed,Tomography(CT) system, NeuViz 16 multi-slice ... is also marked as the first of its kind ... shipped to its U.S.-based customers,recently, Neusoft Medical has made ...
... accident patients may offer a medical heads-up, study says, ... blood-alcohol level of trauma patients could help medical personnel ... issues, a new study says. , People who ... in the dark about potentially serious health needs. But ...
... , , , , ... MedWorks ( www.medworksusa.org ) will provide free access for the ... 8 a.m. to 4 p.m. Saturday and Sunday, July 25 and 26, ... first mass health clinic sponsored by MedWorks and will provide 1100 medical, ...
Cached Medicine News:Health News:Babies Can Comprehend 'Canine' Language 2Health News:Is RTA a new potential option for the treatment of hydatid cysts? 2Health News:Is RTA a new potential option for the treatment of hydatid cysts? 3Health News:Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market 2Health News:Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market 3Health News:Alcohol and Trauma: Blood Test Gets to the Truth 2Health News:U.S. Senator Sherrod Brown to Lend Support at MedWorks' Free Medical Clinic This Weekend 2
1mm by 7mm horizontal punch. Flat serrated handle. Overall length 87mm....
... Central platform with integrated neck. Piston ... utilizing an internal spring to recoil ... Cutting Block fits into precision milled ... blades sized 6.25 - 9.0mm. Designed ...
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
Medicine Products: